|

Dietary Intervention for NSCLC Patients Treated With ICI

RECRUITINGN/ASponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Actively Recruiting
PhaseN/A
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Started2023-04-27
Est. completion2025-03-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05805319

Summary

This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Signed, informed consent
* Age 18 years or older
* Confirmed histological diagnosis of non-small cell lung cancer (NSCLC); Treatment with standard-of-care ICI
* Ability to eat solid foods

Exclusion Criteria:

* Severe dietary allergies (e.g. shellfish, nuts, seafood)
* Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.

Conditions3

CancerLung CancerNon Small Cell Lung Cancer

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.